Prescription drugs and medicines for trauma and emergency medicine (physical wounds or injuries). Studies in these areas include: athletic injuries, burns, Chronic Obstructive Pulmonary Disease (COPD), traumatic brain injuries, and others.
The list of FDA approved drugs for Emergency Medicine appears below. Click any link to view the full drug information.
For the prevention of peri-operative and peri-partum thromboembolic events
For postsurgical analgesia
Gel wound dressing
For the reversal of vitamin K antagonist therapy-induced coagulation factor deficiency
For the treatment of neuropathic pain associated with spinal cord injury
Treatment for chronic and acute wounds
For the treatment of von Willebrand disease
For the prevention of post-operative, chemotherapy and radiotherapy induced nausea and vomiting
FDA Approved Emergency Medicine Listings:
The rules of principle for evaluating MediLexicon's FDA emergency medicine listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The emergency medicine drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.